Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, Par Value $0.01 Per Share
Symbol
ANIK on Nasdaq
Shares outstanding
14,033,333
Price per share
$9.61
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
12,231,313
Total reported value
$114,982,192
% of total 13F portfolios
0%
Share change
-467,783
Value change
-$5,971,102
Number of holders
113
Price from insider filings
$9.61
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Caligan Partners LP 10% $14,365,651 1,435,130 Caligan Partners LP 19 Nov 2025
BlackRock, Inc. 6.8% -35% $14,475,062 -$8,939,904 963,078 -38% BlackRock, Inc. 31 Mar 2025
BlackRock Portfolio Management LLC 5.5% $7,454,957 793,359 BlackRock Portfolio Management LLC 30 Sep 2025
DIMENSIONAL FUND ADVISORS LP 4.5% $9,880,046 657,355 Dimensional Fund Advisors LP 31 Dec 2024
Trigran Investments, Inc. 1.2% -91% $1,618,745 -$13,965,184 168,400 -90% Trigran Investments, Inc. 31 Dec 2025

As of 30 Sep 2025, 113 institutional investors reported holding 12,231,313 shares of Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK). This represents 87% of the company’s total 14,033,333 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) together control 77% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 12% 1,741,762 +14% 0% $16,372,563
Trigran Investments, Inc. 12% 1,621,215 -20% 2.8% $15,239,422
Caligan Partners LP 10% 1,435,130 0% 1.9% $13,490,222
VANGUARD GROUP INC 5.6% 780,663 +0.15% 0% $7,338,232
ACADIAN ASSET MANAGEMENT LLC 4.5% 632,791 +9.9% 0.01% $5,941,000
DIMENSIONAL FUND ADVISORS LP 4.3% 601,163 -3.5% 0% $5,650,730
CAPITAL MANAGEMENT CORP /VA 3.9% 551,248 +35% 0.81% $5,181,727
BOOTHBAY FUND MANAGEMENT, LLC 3.8% 539,642 +1.9% 0.13% $5,072,635
RENAISSANCE TECHNOLOGIES LLC 3.8% 533,017 +1.1% 0.01% $5,010,360
MORGAN STANLEY 2.8% 394,741 +264% 0% $3,710,565
GEODE CAPITAL MANAGEMENT, LLC 2.4% 335,681 +4.5% 0% $3,156,398
STATE STREET CORP 2.3% 323,378 -0.3% 0% $3,039,753
D. E. Shaw & Co., Inc. 1.2% 175,315 +41% 0% $1,647,961
ENVESTNET ASSET MANAGEMENT INC 0.93% 130,809 +7.8% 0% $1,229,605
NORTHERN TRUST CORP 0.85% 119,112 +3.9% 0% $1,119,653
JACOBS LEVY EQUITY MANAGEMENT, INC 0.78% 109,814 -8% 0% $1,032,252
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.74% 103,870 -22% 0% $976,378
Cove Street Capital, LLC 0.73% 101,956 +38% 1.3% $958,386
GLOBEFLEX CAPITAL L P 0.62% 87,600 0% 0.13% $823,440
MILLENNIUM MANAGEMENT LLC 0.62% 86,874 -35% 0% $816,616
DEUTSCHE BANK AG\ 0.58% 81,290 0% 0% $764,126
TWO SIGMA INVESTMENTS, LP 0.57% 79,921 0% $751,257
MARSHALL WACE, LLP 0.53% 73,724 +224% 0% $693,006
GOLDMAN SACHS GROUP INC 0.46% 64,975 +150% 0% $610,765
Quantinno Capital Management LP 0.42% 58,594 +337% 0% $550,784

Institutional Holders of Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 64,231 $617,261 -$312,095 $9.61 6
2025 Q3 12,231,313 $114,982,192 -$5,971,102 $9.40 113
2025 Q2 12,685,136 $134,203,655 -$1,529,080 $10.58 101
2025 Q1 12,677,819 $190,700,389 +$2,180,085 $15.03 107
2024 Q4 12,529,681 $206,235,010 -$14,093,626 $16.46 107
2024 Q3 13,093,708 $323,525,187 -$7,570,043 $24.70 121
2024 Q2 13,238,350 $335,327,300 -$3,265,663 $25.33 113
2024 Q1 13,404,303 $340,492,287 -$1,183,265 $25.40 119
2023 Q4 11,200 $253,792 -$539,059 $22.66 1
2023 Q3 13,003,866 $242,256,831 -$5,557,575 $18.63 115
2023 Q2 13,100,461 $340,372,408 +$436,209 $25.98 116
2023 Q1 13,079,037 $375,621,573 -$1,049,522 $28.72 118
2022 Q4 13,106,170 $387,952,287 -$23,774,372 $29.60 123
2022 Q3 13,333,351 $317,350,893 -$2,358,171 $23.80 112
2022 Q2 12,790,550 $285,484,866 -$1,574,154 $22.32 116
2022 Q1 12,945,301 $325,098,225 +$2,544,206 $25.11 111
2021 Q4 13,487,182 $483,258,995 +$10,254,719 $35.83 125
2021 Q3 13,133,351 $558,740,170 -$406,183 $42.56 126
2021 Q2 13,141,854 $568,897,445 -$4,319,361 $43.29 135
2021 Q1 13,309,986 $543,001,178 -$15,059,366 $40.79 144
2020 Q4 13,510,739 $611,370,033 +$251,984 $45.26 154
2020 Q3 13,534,458 $478,960,726 -$7,302,898 $35.39 151
2020 Q2 13,780,977 $519,076,852 +$35,111,792 $37.73 153
2020 Q1 12,925,945 $373,730,182 -$23,025,495 $28.91 155
2019 Q4 13,203,406 $684,478,310 -$12,094,868 $51.85 184
2019 Q3 13,646,853 $749,017,736 -$19,502,627 $54.89 188
2019 Q2 14,024,493 $569,638,989 +$37,428,238 $40.62 163
2019 Q1 13,199,540 $399,184,234 +$13,142,717 $30.24 148
2018 Q4 12,765,105 $429,002,609 -$13,528,073 $33.61 156
2018 Q3 13,139,075 $554,137,864 -$31,423,514 $42.18 152
2018 Q2 13,942,575 $446,137,896 +$47,552,105 $32.00 162
2018 Q1 12,121,840 $602,649,237 +$11,425,604 $49.72 163
2017 Q4 12,404,692 $668,817,564 -$3,460,133 $53.91 164
2017 Q3 12,404,517 $719,433,944 +$3,279,399 $58.00 163
2017 Q2 12,293,351 $606,491,457 +$28,047,566 $49.34 151
2017 Q1 11,841,166 $514,423,351 +$107,744,633 $43.44 150
2016 Q4 10,997,247 $538,411,707 -$2,605,757 $48.96 152
2016 Q3 10,880,646 $520,667,792 -$20,648,610 $47.85 158
2016 Q2 11,471,760 $615,316,180 -$30,846,888 $53.65 157
2016 Q1 11,876,270 $531,314,562 -$11,241,324 $44.72 158
2015 Q4 13,159,915 $474,603,149 -$3,261,040 $38.16 150
2015 Q3 12,473,944 $397,036,901 +$11,116,157 $31.83 134
2015 Q2 11,948,845 $394,662,257 -$15,227,763 $33.03 134
2015 Q1 12,082,393 $497,310,345 +$17,761,071 $41.17 156
2014 Q4 11,679,958 $475,773,891 +$37,036,632 $40.74 158
2014 Q3 11,043,556 $404,914,011 +$34,126,036 $36.66 151
2014 Q2 9,987,532 $462,796,042 -$6,558,918 $46.33 160
2014 Q1 10,108,915 $415,390,325 +$53,509,061 $41.10 151